RxDoctor Payments Data

Haley Stuart, NP

Family · Mobile, ALNPI 1396397774

Payments from drug & device makers

$1,294in general payments, 2019–2025

Across 83 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$408
  • Novo Nordisk$306
  • AbbVie$162
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$83
  • Merck$71
  • Halozyme Inc$68
  • plus $196 from 6 others

What the payments were for

  • Food & beverage$1,294100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,294 in reported general payments places this provider in the 70th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$12,039
Medicare patients
90
Services billed
275

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide34$48,330
EliquisApixaban13$21,287
MounjaroTirzepatide17$19,676
XareltoRivaroxaban16$17,095
Tresiba Flextouch U-100Insulin Degludec17$7,144
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$3,749
Atorvastatin Calcium188$2,601
Albuterol Sulfate HfaAlbuterol Sulfate48$2,199
SynthroidLevothyroxine Sodium19$1,904
Losartan Potassium125$1,739
Rosuvastatin Calcium103$1,640
Levothyroxine Sodium118$1,634
Omeprazole88$1,330
Duloxetine Hcl42$1,215
Candesartan Cilexetil12$984

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$306$48,33034 claims
AbbVieSynthroid$162$1,90419 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,415 family providers in Alabama.

Other family in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →